Full Text View
Tabular View
No Study Results Posted
Related Studies
First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4
This study has been terminated.
( Proof of principle established with completed SAD part )
Study NCT01374503   Information provided by Ablynx

First Received on June 14, 2011.   Last Updated on April 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Volunteers
Interventions listed in this trial
ALX-0651
Placebo
Sponsors listed in this trial
Ablynx


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services